Q: Just wondering if 5G adoption will have any effect (positive or negative) to a company like Sangoma. Does the new network make older equipment obsolete?
Thank you as always.
Peter
Q: Based on a question from a month ago I took a half position in XBC. It’s up 43% since then (thanks!). I’m considering a full position and am okay with risk. My concern is whether there has been too large a run up in the past month, or would you still consider this early days for this stock in an emerging sector?
Q: This was a company discussed on market call today. That’s has had explosive growth and is on the verge of even more in the hot sustainable energy field what are your thoughts ?
Q: Peter, it looks like skies are clear for this stock, but I'd be interested in your opinion. Raymond James forecasts a one year double on this stock "on the back of positive news concerning the TULSA- PRO [prostate cancer treatment which provides non-chemo, non-radiation ablation of affected tissue], starting with the technology’s US FDA clearance last August and then announcing its first US sales a few weeks later, moving the company from a clinical development company to a commercial-stage company."
Also, the company recently paid off all remaining debt with CIBC.
So... what do you see as potential hurdles for this one.
Q: Hi Peter and Crew
Thank you for your excellent work. We have PHO, PNG and GSI. Thinking of adding CTS to this mix. (this is our small cap fund) Love the growth in CTS and we can hold for five years. What do you think of the choice or any other ideas that may be better.
PS
Thanks for Shop:) wow!!
cheers
Ken and Cindy
Q: I've happily held CJT for years and trimmed when it gets close to 5% which it is now nearing again. The chart is looking a bit scary, but with the Amazon deal , would you let it ride higher than 5% as part of the 'growth' portion of a balanced portfolio ?
Thanks, as always, for your opinon.
Q: Which of these companies do you feel has the most growth potential and which of these is reasonably priced. Also, any other information you know about these companies.
Q: Re: "Baby Brother Strategy"
I read PH's FP article of 06/20/19 as it echoed my own thoughts about AT (though I do not pretend to possess the same analytical tools).
Could you elaborate further on that idea? I was also wondering if you can speak to programmatic advertising and if AT has any competitive advantages or moats or is it simply going head to head with TTD and others? Thank you.
Q: Hi 5i Team - Could you provide some fundamentals on Score such as debt, cash on hand, insider holdings/buying and any other metrics that you think are important. Also do you think their cash flow is reasonable or could there be a concern down the line. Thanks.